Phreesia, Inc. Common Stock (PHR)

Phreesia isn't frozen solid, but it does seem set to grow slower.

The digital healthcare landscape faced a harsh reality check on February 6, 2026, as shares of Doximity, Inc. (NYSE: DOCS) plummeted 17% in early trading. Despite reporting fiscal third-quarter results that surpassed analyst estimates for both revenue and earnings, the professional network for physicians issued a tepid outlook for the

The digital health landscape faced a sobering milestone this week as shares of Doximity, Inc. (NYSE: DOCS), the leading professional network for physicians, plummeted to a new 52-week low. On January 12, 2026, the stock touched $43.21, marking a dramatic retreat from its February 2025 peak of $85.21.

The company's third-quarter performance wasn't nearly as bad as the investor reaction to it might suggest.

Phreesia reports profitable Q3 with strong earnings beat and raises financial outlook following its strategic AccessOne acquisition.

Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase

Phreesia gains analyst support with price target hikes, though integration risks and modest guidance raise tempered investor enthusiasm.

After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.